Toru Imai
Overview
Explore the profile of Toru Imai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hashidzume A, Imai T, Deguchi N, Tanibayashi T, Ikeda T, Michitaka T, et al.
RSC Adv
. 2023 Feb;
13(6):4089-4095.
PMID: 36756559
To realize sustainable societies, the production of organic compounds not based on fossil resources should be developed. Thus, C1 chemistry, utilizing one-carbon compounds as starting materials, has been of increasing...
12.
Matsuoka M, Imai T, Iwabuchi S, Kinoshita K
J Emerg Med
. 2022 Nov;
64(1):62-66.
PMID: 36450616
Background: Amoxapine is a second-generation tricyclic antidepressant with a greater seizure risk than other antidepressants. If administered in large amounts, amoxapine can cause severe toxicity and death. Therefore, it is...
13.
Terada Y, Takahashi T, Hayakawa T, Ono A, Kawata T, Isaka M, et al.
JCO Clin Cancer Inform
. 2022 Sep;
6:e2200070.
PMID: 36162012
Purpose: Several studies reported the possibility of predicting genetic abnormalities in non-small-cell lung cancer by deep learning (DL). However, there are no data of predicting gene rearrangement () using DL....
14.
Isaka M, Kojima H, Imai T, Konno H, Mizuno T, Nagata T, et al.
Gen Thorac Cardiovasc Surg
. 2022 May;
70(11):977-984.
PMID: 35543932
Objective: Lobe-specific nodal dissection (LND) is increasingly used for non-small cell lung cancer (NSCLC) in Japan; however, its treatment validity remains unclarified. Since 2013, LND has been used as a...
15.
Kodama K, Imai T, Asai Y, Kozu Y, Hayashi K, Shimizu T, et al.
J Clin Pharm Ther
. 2022 Mar;
47(7):1070-1078.
PMID: 35313385
What Is Known And Objective: Nafamostat mesylate (NM) is used clinically in combination with antiviral drugs to treat coronavirus disease (COVID-19). One of the adverse events of NM is hyperkalaemia...
16.
Imai T, Hazama K, Kosuge Y, Suzuki S, Ootsuka S
Sci Rep
. 2022 Feb;
12(1):2631.
PMID: 35173236
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for their antipyretic, analgesic, and anti-inflammatory properties. However, various aspects of NSAID-induced lower gastrointestinal tract injury remain unclear, and effective prophylaxis has not...
17.
Hidaka Y, Imai T, Inaba T, Kagawa T, Omae K, Tanaka S
PLoS One
. 2021 Dec;
16(12):e0261703.
PMID: 34941937
Vonoprazan, a potassium-competitive acid blocker, is expected to be superior to proton pump inhibitors (PPIs) in preventing post-endoscopic submucosal dissection (ESD)-induced gastric bleeding. However, the results of randomized controlled trials...
18.
Ford A, Hsu H, Binkley M, Rogers S, Imai T, Maslov K, et al.
Am J Hematol
. 2021 Oct;
97(1):E11-E14.
PMID: 34687466
No abstract available.
19.
Sekimoto M, Imai T, Hidaka S, Chiba N, Sakurai A, Hata M, et al.
J Clin Pharm Ther
. 2021 Aug;
47(3):407-410.
PMID: 34339547
What Is Known And Objective: Favipiravir is a promising treatment candidate for managing coronavirus disease 2019 (COVID-19). Warfarin has many drug interactions, but no interactions with favipiravir have been reported....
20.
Kishaba T, Maeda A, Fukuoka S, Imai T, Takakura S, Yokoyama S, et al.
J Med Invest
. 2021 May;
68(1.2):192-195.
PMID: 33994470
This report presents a case of a 74-year-old man who showed dramatic therapeutic response to treatment of coronavirus infectious disease-19 (COVID-19) pneumonia. He reported four-day history of sustained fever and...